Literature DB >> 11096700

Subarachnoid Hemorrhage.

K D Flemming1, R D Brown, D O Wiebers.   

Abstract

All patients who present with subarachnoid hemorrhage should be admitted to the intensive care unit for close neurologic and cardiorespiratory monitoring. Neurosurgical consultation should be obtained if external ventricular drain placement, arteriography, or surgical planning are considered. Seizure prophylaxis, antihypertensive treatment for mean arterial blood pressure greater than 130 mm Hg, pain control, and bed rest are important measures for the prevention of rebleeding, which is associated with a high mortality rate. Standard deep venous thrombosis and gastrointestinal prophylaxis are recommended to prevent medical complications associated with critical illness. In patients with good-grade subarachnoid hemorrhage, early arteriography and definitive aneurysm management are recommended. The location and neck size of the aneurysm and the medical condition of the patient are factors in the decision to proceed with surgical rather than interventional aneurysm management. Postoperatively, clinical examination and transcranial Doppler ultrasonography are recommended for surveillance of vasospasm. If clinical or arteriographic evidence of vasospasm is present, hemodilution, hypertension, and hypervolemia (triple H) therapy should be instituted. If vasospasm is resistant to conservative measures, balloon angioplasty or intra-arterial papaverine therapy should also be considered.

Entities:  

Year:  1999        PMID: 11096700     DOI: 10.1007/s11940-999-0010-z

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  18 in total

1.  A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America.

Authors:  E C Haley; N F Kassell; C Apperson-Hansen; M H Maile; W M Alves
Journal:  J Neurosurg       Date:  1997-03       Impact factor: 5.115

Review 2.  The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage.

Authors:  G K Bejjani; W O Bank; W J Olan; L N Sekhar
Journal:  Neurosurgery       Date:  1998-05       Impact factor: 4.654

3.  The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results.

Authors:  N F Kassell; J C Torner; J A Jane; E C Haley; H P Adams
Journal:  J Neurosurg       Date:  1990-07       Impact factor: 5.115

4.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

Authors:  W E Hunt; R M Hess
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

5.  Effect of fluid intake and antihypertensive treatment on cerebral ischemia after subarachnoid hemorrhage.

Authors:  D Hasan; M Vermeulen; E F Wijdicks; A Hijdra; J van Gijn
Journal:  Stroke       Date:  1989-11       Impact factor: 7.914

6.  Clinical application of mild hypothermia in neurological disorders.

Authors:  T Maekawa; A Tateishi; D Sadamitsu; Y Kuroda; Y Soejima; S Kashiwagi; T Yamashita; H Ito
Journal:  Minerva Anestesiol       Date:  1994-10       Impact factor: 3.051

7.  A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.

Authors:  J M Findlay; N F Kassell; B K Weir; E C Haley; G Kongable; T Germanson; L Truskowski; W M Alves; R O Holness; N W Knuckey
Journal:  Neurosurgery       Date:  1995-07       Impact factor: 4.654

8.  Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning.

Authors:  C M Fisher; J P Kistler; J M Davis
Journal:  Neurosurgery       Date:  1980-01       Impact factor: 4.654

9.  Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand.

Authors:  N F Kassell; E C Haley; C Apperson-Hansen; W M Alves
Journal:  J Neurosurg       Date:  1996-02       Impact factor: 5.115

Review 10.  Intra-arterial papaverine treatment for cerebral vasospasm: our experience and review of the literature.

Authors:  Y Numaguchi; G H Zoarski
Journal:  Neurol Med Chir (Tokyo)       Date:  1998-04       Impact factor: 1.742

View more
  2 in total

Review 1.  Deep venous thrombosis prophylaxis.

Authors:  Paul Vespa
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

2.  The effect of irrigation of intracisternal papaverine on cerebral blood flow in subarachnoid hemorrhage.

Authors:  Masih Sabouri; Paiman Rahmani; Majid Rezvani; Hossein Nikbakht; Ahmadreza Rafiee; Mostaffa Torkashvand; Noorollah Eshraghi; Nahalossadat Nourian; Mehran Moradi
Journal:  Adv Biomed Res       Date:  2013-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.